US Patent 7348358 Use of cyclolignans
Patent 7348358 was granted and assigned to Axelar AB on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+377 characters)
Article
Patent abstract
The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9′ have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07348358 Use of cyclolignans US Patent 7348358 Use of cyclolignans
Infobox
Patent Number
0734835800
Patent Number
734835800
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
073483580
Date of Patent
March 25, 2008
0Patent Application Number
104814410
Date Filed
June 19, 2002
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
073483580
Date of Patent
March 25, 2008
0Patent Application Number
104814410
Date Filed
June 19, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07348358 Use of cyclolignans
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07348358
Date of patent
March 25, 2008
Patent application number
10481441
Date Filed
June 19, 2002
Patent primary examiner
Find more entities like US Patent 7348358 Use of cyclolignans
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
